Navigation Links
Taking Aim With Nanoparticle PEBBLEs

deliver to cancer cells is too unstable to wander off and damage healthy cells, so only targeted cells are affected. Including molecules that make PEBBLEs more visible in MRI images provides an added bonus, helping to show where tumors are located and how they respond to treatment.

In recent experiments with a small number of rats that had a type of brain cancer called 9L-gliosarcoma, PEBBLE-based treatment significantly increased survival time. People who get that type of cancer usually live less than four months without treatment; rats die within about five days. When Kopelman's group treated rats with PEBBLEs that weren't even tailored to home in on cancer cells, the rats lived twice as long. With targeted PEBBLEs, some rats were still alive and active two months later, and MRI images showed that their tumors had vanished.

Kopelman and coworkers plan to tinker with the PEBBLEs a bit more before trying them on larger numbers of rats, and PEBBLE-based cancer treatments for people are a long way off. But "there's no doubt," said Kopelman, "that nanoparticles such as PEBBLEs can do a fantastic job for therapy, diagnostics and a combination of the two."

Kopelman's collaborators on the work he will discuss in San Diego are Martin Philbert, professor of toxicology and Associate Dean for Research in the School of Public Health; Brian Ross, a professor of biological chemistry and of radiology in the Medical School; Alnawaz Rehemtulla, an associate professor of environmental health sciences, radiation oncology and radiology with joint appointments in the Medical School and the School of Public Health; and Yong-Eun Lee Koo, a research associate in the chemistry department, College of Literature, Science and the Arts.

To date, the researchers have received $11.5 million from the National Cancer Institute for their work with PEBBLEs.

Related links:

* Raoul Kopelman (http://ipumich.temppublish.com/public/experts/ExpDisplay.php?b
'"/>

Source:University Of Michigan


Page: 1 2 3

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. Taking the piste out of Alpine vegetation
3. Taking a flying jump
4. Taking a bite out of a fellow worker helps wasps recruit new foragers
5. Taking evolutions temperature: Researchers pinpoint the energy it takes to make a species
6. Taking the wrinkles out of motoneuronal disease
7. Taking chips to the next level of gene hunting
8. Cancer vaccines -- Taking a jab at cancer by stimulating the immune system
9. DNA Molecules Used To Assemble Nanoparticles
10. Imaging Lymph Nodes with Nanoparticles
11. Probing The Promise And Perils Of Nanoparticles
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Taking Aim With Nanoparticle PEBBLEs

(Date:12/1/2008)...mprehensive "inventory" of sea and land animals ar... that is rich in biodiversity and has more species...nt benchmark to monitor how they will respond to f...k in the Journal of Biogeography , the team from ..., describe how they combed the land, sea and shore...
(Date:12/1/2008)...iscovery based on epigenetics (the inheritance of ...nsuming cholinea nutrient found in eggs and other ...ast cancer outcomes for a mother,s offspring. This...ity is the first to link choline consumption durin... to identify possible choline-related genetic chan...
(Date:11/30/2008)... your levels of "good cholesterol" are good enough... of The FASEB Journal suggests that you may want...he University of Chicago challenge the conventiona...olesterol (HDL) and low levels of bad cholesterol ...how that the good cholesterol has varying degrees ...
(Date:11/30/2008)...Calif. A study describing how cells within blood ... common in the age of genomics that the proteins ...ng that it would be near impossible to group them ... researchers at the Stanford University School of ...ns each control one of four simple activities invo...
Breaking Biology News(10 mins):Eating eggs when pregnant affects breast cancer in offspring 2Cell movements totally modular, Stanford study shows 2Cell movements totally modular, Stanford study shows 3Onyx Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference 14099 1Onyx Pharmaceuticals to Present at Cowen and Company Health Care Conference 3883 1Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference 14095 1Super Bowl Champion Eli Manning Challenges Nation to Be Active 14093 1
...ogy can be used to identify each stage of skin can...ewly published report. , Melanomas grow in two pha...e more likely to metastasize (spread cancer to oth...ristopher Haqq and colleagues dissected a large pr...and through microarray techniques found that, in t...
...o Clinic researchers and conducted by the North Ce...a new "smart" drug treatment for an incurable form...more than one-third of the 65 adult patients who t...creening technique to help predict which patients ...chers will present these findings at the 2005 Amer...
...ts from Colombia, the United States and elsewhere ...or the genetic problems behind the very rare Rober...nclude cleft lip and palate and shortened limbs th...lidomide during pregnancy. , The discovery, which ... of Nature Genetics, proves that genes behind very...
...ntal evidence that birds can be deceived by camouf...published today in Nature [3 March 2005]. , The i... the body,s outline was rapidly adopted by many ar...ology this idea of ,disruptive colouration, has lo...conceal themselves from predators, shaping the evo...
Other Biology News:'Smart drug' targets deadly brain cancer 2'Smart drug' targets deadly brain cancer 315-year hunt finds cause of pseudothalidomide syndrome 215-year hunt finds cause of pseudothalidomide syndrome 315-year hunt finds cause of pseudothalidomide syndrome 4
(Date:12/1/2008)...wire-FirstCall/ -- Isis Pharmaceuticals,Inc. (Na... , What: New findings published in the jou..., known as miR-21, in heart failure, When: ...a.m. PT, Where: http://www.isispharm.com ,...to our website listed above., , If you a...
(Date:12/1/2008)... from a California company aided in the research o...ssociate professor of biomedical engineering. Hyun...e, which he will present this summer to his resear... Macon, GA (PRWEB) December 1, 2008-- A ...ch of vein treatment methods led by Dr. Sinjae H...
(Date:12/1/2008)...tCall/ -- Cell Therapeutics, Inc. (CTI),(Nasdaq a...nd Drug,Administration (FDA) has accepted for fil...tatus for, the supplemental Biologics License Appl...umomab tiuxetan) as consolidation,therapy for pat...a who achieve,a response to first-line therapy. P...
(Date:11/28/2008)...FirstCall/ -- Encorium Group, Inc.,(Nasdaq: ENC...h organization,(CRO) conducting studies in over 3...aceutical and biotechnology companies, today annou...ter from Nasdaq stating that since it had not yet,...tember 30, 2008 as of the,date of the letter, it ...
Breaking Biology Technology:Gift Aids Professor's Research into Vein Treatment 2Gift Aids Professor's Research into Vein Treatment 3Gift Aids Professor's Research into Vein Treatment 4FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review 2FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review 3FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review 4FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review 5Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing 2Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing 3
...lecular diagnostics and drug discovery is expandin...istribution capability of Prodesse, Inc. , a biot...ense agreement, Prodesse will add to its offerings...sion (LUX) technology from the Carlsbad, Calif.-ba...f multiplex polymerase chain-reaction technologies...
...nancial Executives International , a 15,000-peer n... and audit committee members, has announced the fo...ity influence. , ,The group offers an opportunity ...the ethics, highest standards, and best practices ...business dynamics of the Madison area are differen...
...y Geoff Bastow , will dissect topics that interse...nity, including: entrepreneurship in IT, insights...chnology trends that are driving real business val...is. - At the dawn of the dot-com era and through...of 2000, Kenosha entrepreneur John Weiss was on ce...
...ency and power solutions giant Johnson Controls, ... positions reflecting the creation an Executive Op...nd executive vice president, was named chairman of... An employee of Johnson Controls since 1982, Roell...cer from 1991 to 2004. He was named executive vice...
Other Biology Technology:Prodesse joins forces with Invitrogen 2Leadership insights from co-founder of Yesmail 2Leadership insights from co-founder of Yesmail 3Leadership insights from co-founder of Yesmail 4Leadership insights from co-founder of Yesmail 5
Request Info
...namycin resistance gene that confers resistance to...on of multiple insertion events can be identified ...gent. Pichia transformants are selected on histidi...f resistance to Geneticin Reagent. The ability to ...
Clone/PAD: ZMD.478. Immunogen: Synthetic peptide derived from the C-terminal region of the humanmouse and bovine Math-2. Specificity: Specific for the Math2 protein. Reactivity: Human Rat (positiv
Western Blot from Covance Research Products, Inc
Biology Products: